Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ascorbic acid + caffeine + glucuronamide
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Guronsan is an over-the-counter (OTC) antiasthenic and detoxifying combination drug containing glucuronamide, ascorbic acid (vitamin C), and caffeine. It is widely used for the symptomatic treatment of temporary fatigue (functional asthenia) and to assist in the elimination of endogenous and exogenous toxins (such as those from alcohol consumption, smoking, or drug intolerances). Glucuronamide acts as a precursor to glucuronic acid, facilitating the glucuronidation pathway in the liver to promote detoxification and excretion of xenobiotics. Ascorbic acid serves as an essential antioxidant and cofactor, helping to replenish vitamin C levels and combat oxidative stress. Caffeine acts as a central nervous system stimulant by antagonizing adenosine receptors, providing an immediate boost in alertness and physical performance.
- Brand names
- Guronsan
- Other names
- ascorbic acid + caffeine + glucuronamidecaffeine + ascorbic acid + glucuronamideglucuronamide + ascorbic acid + caffeine
02
Targets
ADORA2A (Adenosine A₂A Receptor)ADORA1 (Adenosine receptor A1 subtype)
Beyond the preview
Go deeper on ascorbic acid + caffeine + glucuronamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ascorbic acid + caffeine + glucuronamide.